L. H. van der Meer-Kappelle

Cost impact of procalcitonin-guided decision making on duration of antibiotic therapy for suspected early-onset sepsis in neonates

S. Polinder, R. Moonen, A. V. van Rossum, 2021, Critical Care.

Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial.

K. Allegaert, O. Norbruis, L. V. van Rooij, 2022, The Lancet. Child & adolescent health.

C-Reactive Protein, Procalcitonin, and White Blood Count to Rule Out Neonatal Early-onset Sepsis Within 36 Hours: A Secondary Analysis of the Neonatal Procalcitonin Intervention Study.

F. Plötz, P. Heath, R. Moonen, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Machine Learning Used to Compare the Diagnostic Accuracy of Risk Factors, Clinical Signs and Biomarkers and to Develop a New Prediction Model for Neonatal Early-onset Sepsis

Julia E. Vogt, F. Plötz, R. Moonen, 2021, The Pediatric infectious disease journal.

Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns)

S. Willemsen, S. Kittanakom, M. Nelle, 2017, The Lancet.